Indaptus Therapeutics, Inc.
INDP
Last
$2.51
Day
+5.9%
1y
-45.0%
5y
-98.8%
52w
-60.2%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1132d
EMA 21
2.62
EMA 50
2.41
EMA 200
3.33
20d high
-43.8%
5y high
-99.0%
5y range
1th
Positions held
Your positionsINDP isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
7
Hold
watch
Signal
Neutral
Target
$3.23
Stop
$1.65
Stop distance
34.3%
Target vs last
+28.7%
Fundamentals
| Market cap | $315.78M | Enterprise value | $304.23M | Trailing P/E | — | Forward P/E | -1.71 |
| PEG | — | Price / book | 27.88 | Beta | 0.97 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -3.2% | ROA | -98.1% | Debt / equity | — |
| Current ratio | 19.48 | Free cash flow | -$9.67M | Analyst recommendation | none | Mean target | — |
| 52w high | $5.96 | 52w low | $0.92 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$1.8M | -$2.5M | -$8.1M | -$3.0M | -$5.2M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$1.8M | -$2.2M | -$8.2M | -$2.6M | -$4.5M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$20.8M | -$15.0M | -$15.4M | -$14.3M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$19.8M | -$15.4M | -$16.4M | -$14.9M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-25 · MRNA On Track To Be September's No. 2 S&P 500 Stock — But These 5 Smaller Health Care Names Did Even Better
2026-09-10 · Indaptus Therapeutics Shares Rise After Entering $24 Million Private Placement
2026-08-13 · Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Price (daily)
Full chart · RSI · MACD · patternsINDP · daily-40.6% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin